David Ellis
29Patents
8h-index
46Co-inventors
75Inventor score
Filing activity: Jan 14, 1986 → Nov 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5750520A | Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives | Human Necessities | 47 | Expired |
| US5861393A | Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives | Human Necessities | 34 | Expired |
| US4766121A | Pyridyl and pyridazinyl substituted thyronine compounds having selective thyromimetic activity | Chemistry; Metallurgy | 32 | Expired |
| US6914160B1 | Oxytocin inhibitors | Chemistry; Metallurgy | 30 | Expired |
| US8722691B2 | Azolopyrimidines as inhibitors of cannabinoid 1 activity | Chemistry; Metallurgy | 28 | Active |
| US4826876A | Chemical compounds having selective thyromimetic activity | Chemistry; Metallurgy | 24 | Expired |
| US7205328B2 | Oxindoles with anti-HIV activity | Chemistry; Metallurgy | 21 | Expired |
| US4910305A | Pyridyl and pyridazinyl substituted thyronine compounds | Chemistry; Metallurgy | 21 | Expired |
| US7834009B2 | 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds | Human Necessities | 8 | Active |
| US7557131B2 | Substituted triazole derivatives as oxytocin antagonists | Human Necessities | 5 | Active |
| US9023872B2 | Substituted triazole derivatives as oxytocin antagonists | Human Necessities | 2 | Active |
| US8207198B2 | Substituted triazole derivatives as oxytocin antagonists | Human Necessities | 2 | Active |
| US8158634B2 | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | Chemistry; Metallurgy | 1 | Active |
| US9394278B2 | Substituted triazole derivatives as oxytocin antagonists | Human Necessities | 1 | Active |
| US9604949B2 | Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension | Chemistry; Metallurgy | 1 | Active |
| US8569345B2 | Compounds and compositions as LXR modulators | Chemistry; Metallurgy | 0 | Active |
| US7495016B2 | Pyrrolidones with anti-HIV activity | Chemistry; Metallurgy | 0 | Expired |
| US10016441B2 | Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension | Chemistry; Metallurgy | 0 | Active |
| US8158662B2 | Compounds and compositions as LXR modulators | Chemistry; Metallurgy | 0 | Active |
| US10150752B2 | Substituted triazole derivatives as oxytocin antagonists | Human Necessities | 0 | Active |
| US7875615B2 | Substituted triazole derivatives as oxytocin antagonists | Chemistry; Metallurgy | 0 | Active |
| US7649003B2 | Substituted triazole derivatives as oxytocin antagonists | Chemistry; Metallurgy | 0 | Active |
| US6211223A | Indole derivatives useful in therapy | Human Necessities | 0 | Expired |
| US7291640B2 | Substituted triazole derivatives as oxytocin antagonists | Chemistry; Metallurgy | 0 | Expired |
| US7019141B2 | Quinolones with anti-HIV activity | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.